Article Information
History
- November 2, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maura Malpetti1,
- Luca Passamonti1,2,
- Timothy Rittman1,
- P. Simon Jones1,
- Patricia Vázquez Rodríguez1,
- W. Richard Bevan-Jones3,
- Young T. Hong1,
- Tim D. Fryer1,
- Franklin I. Aigbirhio1,
- John T. O’Brien3,4,* and
- James B. Rowe1,4,*,†
- 1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- 2Institute of Molecular Bioimaging and Physiology, National Research Council, Milano, Italy
- 3Department of Psychiatry, University of Cambridge, Cambridge, UK
- 4Cambridge University Hospitals NHS Trust, Cambridge, UK
- ↵†Corresponding Author: Prof. James B. Rowe, Department of Clinical Neurosciences, University of Cambridge, Herchel Smith Building, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge CB2 0SZ, Tel. no: +44 1223 760 696, Email: james.rowe{at}mrc-cbu.cam.ac.uk
Posted November 02, 2019.
PET markers of tau and neuroinflammation are co-localized in progressive supranuclear palsy
